fashion -WSS

fashion

author：knowledge 2025-09-06 03:40:46 - browse：2845

Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT — Adobe

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

“This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： In key trial, Verve's treatment lowers cholesterol levels in patients

explore

WSS

Morphosys mixed study results for blood cancer drug

Listen: Your guide to Wegovy's blockbuster heart study

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

After John Oliver segment, STAT readers share their opioid

Surge of respiratory disease in China has likely explanation

leisure time

fashion

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Dobbs anniversary: the lost opportunity of abortion as health care

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

focus

Faced with fears of OxyContin misuse, sales reps touted its safety

Newly revealed memo details efforts to keep Trump in power following election loss

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

GOP presidential candidates start declaring their loyalty

Readout LOUD podcast: A CRISPR milestone, biotech mixology

knowledge

focus

explore

leisure time